homesitemapcontact us






About vBloc® Therapy


vBloc® Maestro® System




Clinical Experience






     Cardiovascular Disease




Clinical Experience in Diabetes

Type 2 diabetes is an escalating global health epidemic often related to obesity that affects nearly 200 million people worldwide. Type 2 diabetes is the most common type of diabetes, accounting for 90-95 percent of people with diabetes. Diabetes is the most common disorder of the endocrine (hormone) system and occurs when the body cannot regulate blood sugars. Those with diabetes are susceptible to cardiovascular morbidity and mortality, and up to two out of three people with diabetes have high blood pressure.

EnteroMedics® believes its proprietary VBLOC® vagal blocking therapy has the potential to be effective in the treatment of diabetes and hypertension associated with obesity. Literature suggests that vagal nerve signaling plays a key role in the control of blood glucose and blood pressure.

Learn more about our clinical trial results >.